抗药性
医学
化疗
药品
肿瘤科
癌症研究
阴性治疗反应
细胞培养
癌症
药理学
内科学
常用化疗药物
生物
遗传学
微生物学
作者
MÁRCIA VANESSA SALES AMARAL,Adrhyann Jullyanne de Sousa Portilho,Emerson Lucena da Silva,Lívia de Oliveira Sales,Jersey Heitor da Silva Maués,Maria Elisabete Amaral de Moraes,Caroline Aquino Moreira-Nunes
出处
期刊:Anticancer Research
[Anticancer Research USA Inc.]
日期:2019-12-01
卷期号:39 (12): 6443-6455
被引量:45
标识
DOI:10.21873/anticanres.13858
摘要
Many types of cancer are initially susceptible to chemotherapy, but during treatment, patients may develop resistance to therapy. Knowing that acquisition of drug resistance is a major clinical problem in antineoplastic treatment, the present work aimed to present, through a literature review, the development of chemoresistant cells lines as a model in experimental oncology. A total of 110 drug-resistant cell lines, mainly from lung tumors and leukemias, have been developed. In addition, it has been observed that the drugs used for induction of resistance represented the drugs used for first-line treatment of each neoplasia, since the ideal chemotherapeutic treatment to induce resistance in vitro aims at a better modulation of the therapeutic response in order to better study the mechanisms of resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI